VVUS

VIVUS, Inc. News Headlines

$3.32
*  
0.15
4.73%
Get VVUS Alerts
*Delayed - data as of Dec. 19, 2014  -  Find a broker to begin trading VVUS now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Predicting Biotech Stock Moves Based On Consensus Picks By Legendary Fund Managers
10/14/2013 8:45:00 AM - Seeking Alpha


Vivus Lands Partner For ED Drug
10/11/2013 2:34:00 PM - Seeking Alpha


Sector Update: Healthcare Shares Flat to Higher; Immunogen up 6% on Licensing to Novartis
10/11/2013 7:07:36 AM - MT Newswires


Sector Update: Healthcare
10/11/2013 7:05:20 AM - MT Newswires


Obesity Drug Makers Vivus and Arena Just Can't Seem to Lighten Up
10/10/2013 11:20:00 AM - Minyanville


New CEO Should Right InVivo's Ship
10/9/2013 1:06:00 PM - Seeking Alpha


Update on Orexigen's Contrave - Analyst Blog
10/8/2013 10:44:45 AM - Zacks.com


A Case For Shorting Biopharma Drug Launches: 4 Recent Examples
10/7/2013 12:49:00 PM - Seeking Alpha


New Stock Coverage: Facebook, General Electric, and Garmin
10/7/2013 8:23:00 AM - Minyanville


Orexigen Seeks Approval In Europe For Anti-Obesity Pill
10/3/2013 11:05:00 PM - Seeking Alpha


Mid-Day Market Update: Dow Slips Below 15000; CalAmp Jumps On Upbeat Results
10/3/2013 11:11:59 AM - Benzinga


Things Just Got A Little Brighter For Vivus
10/3/2013 8:28:00 AM - Seeking Alpha


Will Arena Be Able To Write A Growth Story?
9/30/2013 3:59:00 PM - Seeking Alpha


Billionaires Hold Four Stocks, 59% Off
9/29/2013 12:41:20 PM - GuruFocus


What's Weighing on Obesity Drug Makers Vivus and Arena?
9/26/2013 10:45:00 AM - Minyanville


VIVUS' Hopes Tied to Qsymia - Analyst Blog
9/25/2013 10:17:42 AM - Zacks.com


Novo Nordisk Advertising Weight Loss - A Future Peak At Arena Or Vivus?
9/24/2013 3:14:00 AM - Seeking Alpha


The Biggest Loser: A Compelling Short Opportunity In Vivus
9/20/2013 1:15:00 PM - Seeking Alpha


Vivus Will Try Again In Europe With Anti-Obesity Drug
9/20/2013 12:54:00 PM - Seeking Alpha


Update on Arena/Eisai's Belviq - Analyst Blog
9/18/2013 10:50:01 AM - Zacks.com


EnteroMedics: Arena 2.0?
9/12/2013 6:26:00 AM - Seeking Alpha


Vivus - Silence Is Not Golden
9/10/2013 8:43:00 PM - Seeking Alpha


Strong Acquisition Target Solta Poised To Challenge In Fat Loss And Skin Care Markets
9/10/2013 7:50:00 AM - Seeking Alpha


Vivus' Qsymia Scripts Remain Flat
9/9/2013 5:28:00 AM - Seeking Alpha


Assessing Arena's Belviq Sales After 3 Months
9/9/2013 2:12:00 AM - Seeking Alpha